← FDA DRUG APPROVALS

FDA ANDA · ANDA040303

OXYCODONE AND ACETAMINOPHEN

Sponsor: VINTAGE PHARMS LLC

APPLICATION
ANDA040303
TYPE
ANDA
ORIGINAL APPROVAL
1999-12-30
LATEST ACTION
2002-07-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

OXYCODONE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG, OXYCODONE HYDROCHLORIDE 5MG · CAPSULE · ORAL

Approval history

2002-07-31Manufacturing (CMC) · Supplement 1AP
2002-07-18Manufacturing (CMC) · Supplement 2AP
1999-12-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →